Carregando...

Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014

Cefepime-tazobactam (WCK 4282) is currently under clinical development for use at a dosage of 2 g/2 g every 8 h. A total of 7,981 isolates were collected from 146 medical centers (39 countries) in 2014 as a part of the SENTRY Antimicrobial Surveillance Program, and their susceptibilities to cefepime...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Principais autores: Sader, Helio S., Castanheira, Mariana, Mendes, Rodrigo E., Flamm, Robert K., Jones, Ronald N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5365660/
https://ncbi.nlm.nih.gov/pubmed/28137811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02409-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!